HC Wainwright & Co.: Reiterated its buy rating on Cullinan Therapeutics (CGEM.US), adjusting the target price from $28.00 to $28.00.
HC Wainwright & Co.：重申Cullinan Therapeutics(CGEM.US)评级，由买入调整至买入评级, 目标价由28.00美元调整至28.00美元。
HC Wainwright & Co.: Reiterated its buy rating on Cullinan Therapeutics (CGEM.US), adjusting the target price from $28.00 to $28.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.